Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15026 - 15050 of 15131 in total
R-95845 is an inhibitor of HIV-1 reverse transcriptase.
Experimental
BMS-488043 has been investigated as an anti-HIV agent.
Investigational
CG0070 is investigated in clinical trials for treating bladder cancer. CG0070 is a solid. CG0070 can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and immune-mediated cell killing stimulated by GM-CSF. CG0070, an oncolytic virus therapy with specificity for multiple cancers, has been evaluated...
Investigational
Matched Description: … can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and
4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
LI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. It has a novel mode of action combining both the light effect of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and antagonism...
Investigational
Matched Description: … of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and
Experimental
Investigational
Experimental
Vet approved
Experimental
Displaying drugs 15026 - 15050 of 15131 in total